Nǔ ɖevo lɛ wɛ nɔ zɔ́n bɔ è nɔ jɛ azɔnkwín zɛnzɔn tɔn jí, bɔ ye ɖíe:
1. Xwédo mɛtɔn: Enyi mɛjitɔ́ towe alǒ nɔví towe ɖé ɖó azɔn syɛnsyɛn ɔ, é sixu zɔ́n bɔ azɔn ɔ na gblé we d'eji.
2. Xwè: Xwè mɛtɔn ko ɖò yiyi wɛ é ɔ, awovinú e ɖò te kpɔ́n bɔ a na ɖó azɔnkwín alɔkpa 2 ɔ é nɔ jɛji, ɖò taji ɔ, ɖò xwè 45 mɛtɔn gudo.
3. Nǔ e a nɔ da é: Nǔ e nɔ zɔ́n bɔ a nɔ ɖó azɔn syɛnsyɛn é wɛ nyí ɖɔ a nɔ ɖó zin zɛ jlɛ̌ wu.
4. Nǔwiwa agbaza tɔn e ma nɔ zɔ́n bɔ è nɔ ɖókan dó lanmɛ na nɔ ganji wu ǎ é: Nǔwiwa agbaza tɔn e ma nɔ zɔ́n bɔ è nɔ ɖókan dó lanmɛ na nɔ ganji wu ǎ é sixu zɔ́n bɔ azɔn ɔ syɛn.
5. akɔ alǒ akɔta: Akɔta ɖé lɛ, ɖi Aflika-Amerika-nu lɛ, Hispanique-Amerika-nu lɛ, Amɛlika-Tɔ́gbó lɛ, kpo Azíi-Amerika-nu lɛ kpo wɛ awovinú sukpɔ́ hugǎn bɔ ye na jɛ azɔnkwín alɔkpa 2 ɔ jí.
6. Azɔnkwín nɔ nyí sukpɔ́ ɖò vǐkpo ɔ mɛ hwenu e è ɖò xò é: Asú ɖěɖee ko jɛ azɔn nɔ nyí sukpɔ́ ɖò vǐkpo ɔ mɛ hwenu e è ɖò xò é lɛ é sixu wá jɛ azɔn nɔ nyí sukpɔ́ ɖò vǐkpo ɔ mɛ ɖò xwè e na bɔ d'ewu lɛ é mɛ.
7. Azɔn e nɔ zɔ́n bɔ è nɔ ɖó azin gègě ɖò xomɛ é: Azɔn enɛ nɔ zɔ́n bɔ nyɔnu e ɖó azɔn enɛ lɛ é nɔ ɖó awovinú tawun bo nɔ jɛ azɔnkwín alɔkpa 2 ɔ jí.
8. Acɛkpikpa e nɔ zɔ́n bɔ è nɔ ɖù nǔ ɖò agbaza mɛ é: Acɛkpikpa enɛ lɛ e nɔ zɔ́n bɔ hun nɔ yì jǐ, bɔ nǔ e ɖò agbaza mɛ lɛ é nɔ yì jǐ, bɔ è nɔ lɛ́ ɖù nǔ ɖò kan mɛ lɛ é nɔ zɔ́n bɔ awovinú ɖò mɛ jí bɔ è na wá ɖó azɔn syɛnsyɛn alɔkpa 2 ɔ.
9. Sinsɛn-nǔ nunu: Sinsɛn-nǔ nunu sixu zɔ́n bɔ è na ɖó hǔnzɔn e nɔ zɔ́n bɔ è nɔ ɖó sukpɔ́ ɖò hǔnzɔn ɖé mɛ é ǎ, bɔ enɛ sixu zɔ́n bɔ è na ɖó azɔn syɛnsyɛn alɔkpa wegɔ ɔ.
10. Azɔnkwín e nɔ zɔ́n bɔ è nɔ jɛ sukpɔ́ ɖu jí é: Enyi è nɔ ɖó sukpɔ́ e nɔ zɔ́n bɔ è nɔ jɛ sukpɔ́ ɖu jí é hú ee è ɖó na ɖó é ɔ, é sixu zɔ́n bɔ è na jɛ sukpɔ́ ɖu jí ɖò alɔkpa wegɔ ɔ mɛ.
11. É nɔ kpò ɖò ajidonu: Vǐ e è jì bɔ ye ɖó zin ǎ lɛ é sixu wá jɛ azɔnkwín alɔkpa 2 ɔ jɛ jí ɖò nukɔnmɛ ɖò gbɛzán yetɔn mɛ.
12. Hunsínsínsínɔ́ hunsínɔ́: Hunsínsínɔ́ hunsínɔ́ nɔ zɔ́n bɔ awovinú e nɔ ɖó nú mɛ bɔ è nɔ ɖó azɔnkwín alɔkpa 2 ɔ é nɔ lɛ́ jɛji.
13. Cholesterol kpo triglyceride kpo e ma sɔgbe ǎ é: Cholesterol e nɔ ɖó sinmɛ agbaza tɔn sín nǔ lɛ é gègě kpo cholesterol ɖagbe e è nɔ ylɔ ɖɔ HDL é kpɛɖé kpo nɔ zɔ́n bɔ azinzɔnnɔ lɛ nɔ jɛ azɔn syɛnsyɛn alɔkpa 2 ɔ jí.
14. (a) Hwiɖesunɔ mɛ ninɔ nɔ bɔwǔ nú mɛ lɛ bɔ ye nɔ gɔn amlɔ nu à? (b) Mɛ ɖěɖee nɔ jɛ amlɔ mɛ bɔ ye nɔ gɔn amlɔ nu lɛ é sixu jɛ azɔnkwín alɔkpa 2 ɔ jɛ jí.
15. Adǎn: Adǎn e nɔ ɖó nú mɛ hwebǐnu é sixu zɔ́n bɔ è na ɖó azɔn syɛnsyɛn alɔkpa 2 ɔ.
16. Atínkpo ɖé lɛ: Atínkpo ɖé lɛ, ɖi steroids kpo antipsychotics kpo sixu zɔ́n bɔ azɔnkwín alɔkpa 2 ɔ sixu wá d'ewu.
17. Azɔnkwín: Azɔnkwín e nɔ ɖò jijɛji wɛ hwɛhwɛ é sixu zɔ́n bɔ è na ɖó azɔnkwín alɔkpa 2 ɔ.
18. Nǔwiwa e nɔ zɔ́n bɔ è nɔ cí ayǐ: Nǔwiwa e nɔ zɔ́n bɔ è nɔ cí ayǐ é sixu zɔ́n bɔ è na ɖó azɔn syɛnsyɛn alɔkpa wegɔ ɔ.
19. Nǔɖuɖu e ɖó ami gègě, bo ɖó calorie gègě é: Nǔɖuɖu e ɖó ami e nɔ hɛn lanmɛ na nɔ ganji ǎ lɛ é gègě é sixu zɔ́n bɔ azɔn syɛnsyɛn alɔkpa 2 ɔ sixu wá nú mɛ.
20. ahan nunu: Alɔkpa nu dín sixu zɔ́n bɔ è na ɖó azɔn syɛnsyɛn alɔkpa 2 ɔ.
21. Amlɔ ma ɖ'emɛ: Amlɔ ma ɖ'emɛ ganji sixu zɔ́n bɔ azɔnkwín alɔkpa 2 ɔ sixu wá d'ewu.
22. Gbè e mɛ jɔhɔn nɔ hɛn blí é: Gbè e mɛ jɔhɔn nɔ hɛn blí é sixu zɔ́n bɔ azɔnkwín alɔkpa 2 ɔ sixu gblé mɛ d'eji.
24. Homocysteine e ɖò lanmɛ na nɔ ganji é: Amino acid e nɔ nyí homocysteine é e ɖò lanmɛ na nɔ ganji é sixu zɔ́n bɔ azɔn syɛnsyɛn alɔkpa 2 ɔ sixu wá d'ewu.
25. Acide urique e ɖò lanmɛ ɔ mɛ é: Acide urique e nɔ tɔ́n sín lanmɛ ɔ mɛ é e ɖò lanmɛ ɔ mɛ é sixu zɔ́n bɔ azinzɔnnɔ lɛ na jɛ azɔn syɛnsyɛn alɔkpa 2 ɔ jɛ jí.
26. C-reactive protein e ɖò sukpɔ́ é: C-reactive protein e nɔ ɖè nǔ e ɖò lanmɛ nɔ jɛ wɛ lɛ é xlɛ́ é e ɖò sukpɔ́ é sixu zɔ́n bɔ azɔn syɛnsyɛn alɔkpa 2 ɔ sixu wá d'ewu.
27. Fibrinogen e ɖò hùn mɛ é sukpɔ́: Fibrinogen e nyí nǔ e nɔ zɔ́n bɔ hun nɔ xú é ɖé wɛ, bɔ é sukpɔ́ é sixu zɔ́n bɔ azɔn syɛnsyɛn alɔkpa 2 ɔ sixu wá d'ewu.
28. PAI-1 e ɖò sukpɔ́ é: PAI-1 e nyí nǔ e nɔ zɔ́n bɔ hun nɔ xú é ɖé, bɔ é sukpɔ́ é sixu zɔ́n bɔ azɔn syɛnsyɛn alɔkpa 2 ɔ sixu wá d'ewu.
29. Leptin e ɖò lanmɛ na nɔ ganji mɛ é: Leptin e nyí hormone ɖé bo nɔ wà nǔ dó jlǒ agbaza tɔn wu é e ɖò lanmɛ na nɔ ganji mɛ é sixu zɔ́n bɔ azɔn syɛnsyɛn alɔkpa 2 ɔ sixu wá d'ewu.
30. Resistin e ɖò lanmɛ nú mɛ é: Resistin e nyí hormone e nɔ zɔ́n bɔ è nɔ ɖó sìn e è nɔ ylɔ ɖɔ insuline é ǎ é gègě sixu zɔ́n bɔ è nɔ ɖó azɔn syɛnsyɛn
King WM, Saseen JJ, Anderson SL: Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014, 5 (5): 206-11.
Bielinski SJ, Pankow JS, Rasmussen-Torvik LJ, Bailey K, Li M, Selvin E, Couper D, Vazquez G, Brancati F: Strength of association for incident diabetes risk factors according to diabetes case definitions: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012, 175 (5): 466-72.
Gangwisch JE, Gross R, Malaspina D: Differential Associations Between Depression, Risk Factors for Insulin Resistance and Diabetes Incidence in a Large U.S. Sample. Isr J Psychiatry Relat Sci. 2015, 52 (2): 85-90.
Leiva AM, Martínez MA, Petermann F, Garrido-Méndez A, Poblete-Valderrama F, Díaz-Martínez X, Celis-Morales C: [Risk factors associated with type 2 diabetes in Chile]. Nutr Hosp. 2018, 35 (2): 400-407.
Chatterjee R, Maruthur NM, Edelman D: Novel Risk Factors for Type 2 Diabetes in African-Americans. Curr Diab Rep. 2015, 15 (12): 103.
Higa S, Maesato A, Ishigaki S, Suenari K, Chen YJ, Chen SA: Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation. Card Electrophysiol Clin. 2021, 13 (1): 63-75.
Brodalko B: [Diabetes risk factors in the Regional Railway Hospital in Lublin, described on the basis of medical documentation]. Wiad Lek. 2000, 53 (5-6): 255-61.
['Nǔgbɛnúmɛ: dotóoxwé sín']
['Nǔkplɔnkplɔn kpo nǔsisɔ kpo sín azɔ̌ kɛɖɛ wɛ è nɔ wà dó tɛn ɛntɛnɛti tɔn elɔ jí, bo nɔ na wěɖexámɛ dotóoxwé tɔn alǒ azɔ̌ ɖevo lɛ mɛ ǎ.']
['È ɖó na zán nǔ e è kplɔ́n mɛ lɛ é dó ba azɔn ɖé alǒ azɔn ɖé sín wuntun alǒ dó gbɔ na ǎ, bɔ mɛ ɖěɖee jló na ba wěɖexámɛ dotóo tɔn lɛ é ɖó na yì mɔ dotóo e ɖó acɛ bo nɔ wà azɔ̌ ɖò dotóoxwé é ɖé.']
['Mi ni flín ɖɔ nǔ e è nɔ ylɔ ɖɔ "neural net" bo nɔ na xósin nú nǔkanbyɔ lɛ é ɔ, nǔ e nɔ nyí nǔjɛdo tawun é wɛ nyí nǔ ɖěɖee è nɔ ylɔ ɖɔ "numeric content" lɛ é. Ði kpɔ́ndéwú ɔ, mɛ nabi è mɔ azɔn ɖé na é.']
['Nɔ ba wěɖexámɛ dotóo towe tɔn alǒ dotóo ɖevo e ɖó nǔwukpikpé é tɔn dó azɔn ɖé wu hwebǐnu. Ma wɔn wěɖexámɛ dotóo tɔn lɛ gbeɖé ó, alǒ ma lin tamɛ kpɔ́n dó nǔ e a xà ɖò tɛn ɛntɛnɛti tɔn elɔ jí lɛ é wu ó. Enyi a lin ɖɔ azɔn baɖabaɖa ɖé ɖò xwi ɖí xá we wɛ hǔn, ylɔ 911 alǒ yì dotóoxwé e sɛkpɔ we hugǎn é tlolo. Tɛn ɛntɛnɛti tɔn elɔ alǒ nǔ e a nɔ zán lɛ é nɔ zɔ́n bɔ kancica dotóo-azinzɔnnɔ ɖé tɔn nɔ tíìn ǎ. BioMedLib, azɔ̌watɔ́ tɔn lɛ, alǒ mɛ ɖevo ɖebǔ e nɔ wlan nǔ dó tɛn ɛntɛnɛti tɔn elɔ jí lɛ é nɔ ɖè kúnnuɖenú ɖebǔ xlɛ́, bo tlɛ nɔ ɖɔ lɔ ǎ, dó nǔ e è ɖɔ ɖò fí lɛ é alǒ nǔ e è nɔ zán lɛ é wu.']
['Nǔɖògbɛ́jlatɔ́ lɛ']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) nɔ na acɛ mɛ e ɖó nǔɖokan yetɔn lɛ é bɔ ye na dó ba nǔɖe bo dó sixu mɔ nǔ e ye ɖó lɛ é ɖò Internet jí.']
["Enyi a ɖi nǔ ɖɔ nǔ ɖĕbǔ ɖò tɛn ɛntɛnɛti tɔn mǐtɔn jí alǒ azɔ̌wiwa mǐtɔn lɛ jí bo hɛn nǔ dó así nú mɛ ɔ, é xò nǔ dó acɛ nǔɖògbɛ́ towe lɛ wu ɔ, hwi (alǒ mɛ e nɔ kpé nukún dó wǔ towe é) sixu sɛ́ wɛn dó mǐ, bo byɔ ɖɔ mǐ ni ɖè nǔ ɖ'emɛ lɛ sín tɛn ɔ jí, alǒ ɖɔ mǐ ni sú ali dó mɛ."]
["È ɖó ná sɛ́ mɛ dó gbɔn email jí (e-mail è nɔ dó ɔ́' kpɔ́n 'Kɔntaktɔ́' ɔ́)."]
['DMCA byɔ ɖɔ ɖɔ nǔ elɔ lɛ ni nɔ akpáxwé nǔ e a ɖɔ é gbà acɛ dó nǔ é tɔn jí é: (1) xó dó azɔ̌ e ɖó acɛ dó nǔ é jí; (2) xó dó nǔ e ɖó acɛ dó nǔ é jí, kpo nǔ ɖevo e na zɔ́n bɔ mǐ na mɔ nǔ ɔ lɛ é kpo; (3) xó dó hwiɖée wu, ɖi adlɛsi towe, alokan towe kpo email towe kpo; (4) xó ɖɔ dó nǔ e wu a ɖi nǔ ɖɔ nǔ e ɖó acɛ dó nǔ e jí a ɖɔ é jí é kún nyí nǔ e ɖó acɛ dó nǔ é jí tɔn ɔ, alǒ mɛ e nɔ kpé nukún dó nǔ é tɔn wu é sín acɛ ó; ']
["(5) Ðɛ́ mɛ̀ è mi sɔ́ alɔ dó ɖ'así ná ɖò hwɛɖɔxɔsá ɔ́' è ɖó ná ɖó hwɛ̀ ɖɔ̀ xó è mi ɖɔ ɖò mɛ̀ è mi dó wèmá ɔ́ mɛ̀ ɔ́' sɔgbe bɔ̀ mi ɖó acɛ̀ bó ná dó ba ɖɔ è ní sú nǔ è è dó wèmá ɔ́ wú lɛ́ɛ sín axɔ́."]
['bɔ (6) alɔ wlanwlan mɛ e ɖó acɛ dó nǔ é tɔn alǒ mɛ e ɖó acɛ bo na wà nǔ dó wutu tɔn é tɔn. ']
['Nú a ma gɔ́ nǔ e ɖò jí lɛ é bǐ ǎ ɔ, é sixu zɔ́n bɔ è na lín có bo na dóhwɛ we.']
['Wǎ kpé mì']
['Mi kɛnklɛn bo sɛ́ nǔkanbyɔ mitɔn lɛ dó mǐ gbɔn e-mail jí.']
What are the risk factors for diabetes?
There are several risk factors for diabetes, including:
1. Family history: Having a parent or sibling with diabetes increases your risk.
2. Age: The risk of type 2 diabetes increases as you get older, especially after age 45.
3. Weight: Being overweight or obese increases your risk.
4. Physical inactivity: Lack of exercise can increase your risk.
5. Race or ethnicity: Certain ethnic groups, such as African Americans, Hispanic Americans, Native Americans, and Asian Americans, have a higher risk of developing type 2 diabetes.
6. Gestational diabetes: Women who have had gestational diabetes during pregnancy are at higher risk of developing type 2 diabetes later in life.
7. Polycystic ovary syndrome: Women with this condition have a higher risk of developing type 2 diabetes.
8. Metabolic syndrome: This cluster of conditions, including high blood pressure, high cholesterol, and large waist circumference, increases the risk of type 2 diabetes.
9. Smoking: Smoking can increase insulin resistance, which can lead to type 2 diabetes.
10. Prediabetes: Having prediabetes, or higher than normal blood sugar levels, increases the risk of developing type 2 diabetes.
11. Low birth weight: Babies with low birth weight have a higher risk of developing type 2 diabetes later in life.
12. High blood pressure: Having high blood pressure increases the risk of developing type 2 diabetes.
13. Abnormal cholesterol and triglyceride levels: High levels of triglycerides and low levels of HDL (good) cholesterol increase the risk of type 2 diabetes.
14. Sleep apnea: People with sleep apnea have an increased risk of developing type 2 diabetes.
15. Stress: Chronic stress can increase the risk of developing type 2 diabetes.
16. Certain medications: Some medications, such as steroids and antipsychotics, can increase the risk of developing type 2 diabetes.
17. Inflammation: Chronic inflammation can increase the risk of developing type 2 diabetes.
18. Sedentary lifestyle: A sedentary lifestyle can increase the risk of developing type 2 diabetes.
19. High-fat, high-calorie diet: Consuming a diet high in unhealthy fats and calories can increase the risk of developing type 2 diabetes.
20. Alcohol consumption: Excessive alcohol consumption can increase the risk of developing type 2 diabetes.
21. Sleep deprivation: Inadequate sleep can increase the risk of developing type 2 diabetes.
22. Air pollution: Exposure to air pollution can increase the risk of developing type 2 diabetes.
23. Certain infections: Certain infections, such as hepatitis C, can increase the risk of developing type 2 diabetes.
24. High levels of homocysteine: High levels of homocysteine, an amino acid, can increase the risk of developing type 2 diabetes.
25. High levels of uric acid: High levels of uric acid, a waste product, can increase the risk of developing type 2 diabetes.
26. High levels of C-reactive protein: High levels of C-reactive protein, a marker of inflammation, can increase the risk of developing type 2 diabetes.
27. High levels of fibrinogen: High levels of fibrinogen, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.
28. High levels of PAI-1: High levels of PAI-1, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.
29. High levels of leptin: High levels of leptin, a hormone involved in appetite regulation, can increase the risk of developing type 2 diabetes.
30. High levels of resistin: High levels of resistin, a hormone involved in insulin resistance, can increase the risk of developing
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['E ɖò']
['BioMedLib nɔ zán ordinateur lɛ (algorithme nǔ kplɔnkplɔn mɔto tɔn lɛ) bo nɔ dó kàn nǔ byɔ mɛ lɛ bo nɔ lɛ́ na ye xósin.']
['Mǐ bɛ́ kpodo azɔwanú lanmɛ kpo lanmɛ kpo tɔn livi 35 e ɖò PubMed/Medline lɛ é kpo. Mǐ lɛ́ vɔ́ mɔ tɛn ɛntɛnɛti tɔn RefinedWeb tɔn lɛ.']
